NCT00225264 - Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. | Biotech Hunter

Enrollment

458

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Diabetes Mellitus

Interventions

DRUG

Pioglitazone

Pioglitazone 15 mg titrated up to 45 mg, tablets, orally, once daily and glimepiride placebo-matching capsules, orally, once daily for up to 72 weeks.

DRUG

Glimepiride

Pioglitazone placebo-matching tablets, orally, once daily and glimepiride 1 mg titrated up to 4 mg, capsules, orally, once daily for up to 72 weeks.

Trial Locations (1)

Unknown

Chicago